RAYMOND JAMES & ASSOCIATES - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$131,709
+10.6%
16,951
+37.8%
0.00%
Q2 2023$119,064
-7.9%
12,300
+4.2%
0.00%
Q1 2023$129,328
-7.6%
11,800
+4.4%
0.00%
Q1 2022$140,000
-49.8%
11,300
-10.3%
0.00%
Q3 2021$279,000
-23.1%
12,600
-55.0%
0.00%
Q2 2021$363,000
+143.6%
27,990
+160.4%
0.00%
Q4 2020$149,000
-75.2%
10,750
-74.1%
0.00%
-100.0%
Q1 2020$602,000
+4.5%
41,495
+45.9%
0.00%0.0%
Q4 2019$576,000
+223.6%
28,445
-1.9%
0.00%
Q2 2017$178,00029,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders